Overview
News
Salaries
Products
People
Growth
Offices
Financials

Overview

Ampersand is enabling potent mechanisms to treat disease by creating and programming therapeutics that are more efficacious, without compromising on safety or tolerability.

News

News Arts & Sciences 7 months ago
WashU researchers use quantum biosensors to peer into the inner workings of living cells
A team including scientists from the Center for Quantum Leaps has harnessed nanodiamonds to take quantum readings of mitochondria.
Read more
Report
News MacRumors 1 year ago
Apple Bug Prevents You From Telling People About Dave & Buster's
There's an issue with the Messages app that prevents users from sending voice-based messages that include ampersands, resulting in a curious bug that means you can't use audio messages to tell your friends about Dave & Buster's, H&M, Tiffany & Co., or any
Read more
Report
News softwareengineering.stackexchange.com 3 years ago
C uses "&" for the address-operator because 'ampersand sounds like "address"' Read more
Report
News BostonGlobe.com 3 years ago
Flagship's latest startup aims to develop drugs with fewer side effects - The Boston Globe
Boston-based Ampersand Biomedicines launches with $50 million from the Cambridge firm to design medicines that better target the site of a disease than existing treatments.
Read more
Report
News blog.fiberplane.com 3 years ago
Getting Past
A little mental model for ownership and borrowing
Read more
Report
News MedCity News 3 years ago
Flagship Startup Emerges With $50M to Send Drugs to the Right Biologic Address
Ampersand Biomedicines emerged from stealth with technology for site-specific drug delivery that avoids toxic effects throughout the body. The Flagship Pioneering-founded startup is backed by $50 million in financing.
Read more
Report
News BioCentury 3 years ago
Ampersand, Rapport launches reflect precision medicine trend
Precision medicine was the theme of two new company launches announced on Tuesday. Both Boston-based newcos are aiming for a higher degree of precisio...
Read more
Report
News Chemical & Engineering News 3 years ago
Flagship unveils latest brainchild: Ampersand Biomedicines
The venture capital company commits $50 million to the start-up launch
Read more
Report
News BioPharmaDive 3 years ago
Flagship's latest startup emerges with a plan for 'smarter biologics'
Ampersand Biomedicines claims to be developing a way to make medicines that act only at the site of disease and spare healthy tissue.
Read more
Report
Show more news